世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
オリゴヌクレオチド合成市場。世界の産業動向、シェア、サイズ、成長、機会、および2021-2026年の予測Oligonucleotide Synthesis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026 The global oligonucleotide synthesis market exhibited strong growth during 2015-2020. Oligonucleotide synthesis is a chemical process wherein short fragments of nucleic acids are linked to each oth... もっと見る
サマリーThe global oligonucleotide synthesis market exhibited strong growth during 2015-2020. Oligonucleotide synthesis is a chemical process wherein short fragments of nucleic acids are linked to each other for forming desired sequenced products. It can be customized by researchers according to the application and their requirements. It is used as primers and probes in recombinant DNA technologies to develop monoclonal antibodies. It is also utilized in biological, medical, forensic, and clinical applications for gene expression, cloning, molecular diagnostics, and genetic disease screening. Moreover, it is gaining traction in therapeutics practices for several drugs on account of the introduction of automated reactor platforms, which provide access to oligonucleotides at reasonable prices.With the increasing cases of coronavirus disease (COVID-19) and the urgency for a potential treatment, new generations of oligonucleotide drugs, including mRNA and DNA vaccines, are currently under development. Apart from this, the growing incidences of cancer and other chronic illnesses have resulted in the rising demand for novel diagnostics, which is influencing the need for oligonucleotide synthesis to help develop effective therapies and diagnostic techniques. The increasing geriatric population and demand for personalized medicines are also bolstering the market growth. Additionally, with advances in purification and quality control technologies, the overall cost of oligonucleotide techniques can be decreased while substantially increasing quality and yield. This is promoting the application of oligonucleotide synthesis in a range of available modifications. Apart from this, several oligonucleotide-based therapies are in different stages of clinical trials. This is anticipated to propel the demand for oligonucleotide synthesis to treat viral infections, rare genetic disorders, and neuromuscular conditions. Looking forward, IMARC Group expects the global oligonucleotide synthesis market to grow at a CAGR of 12.7% during the forecast period (2021-2026). Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global oligonucleotide synthesis market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, application and end use. Breakup by Product: Synthesized Oligonucleotide Products Reagents Equipment Services Breakup by Application: PCR Primers PCR Assays and Panels Sequencing DNA Microarrays Fluorescence In-Situ Hybridization (FISH) Antisense Oligonucleotides Others Breakup by End Use: Pharmaceutical and Biotechnology Companies Hospital and Diagnostic Laboratories Academic Research Institutes Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Biolegio B.V., Bio-Synthesis Inc, Eurofins Genomics, GenScript, Horizon Discovery Ltd, Integrated DNA Technologies Inc (Danaher Corporation), Kaneka Eurogentec S.A. (Kaneka Corporation), LGC Limited, Nitto Denko Avecia Inc (Nitto Denko Corporation) and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global oligonucleotide synthesis market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global oligonucleotide synthesis market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global oligonucleotide synthesis market and who are the key players? What is the degree of competition in the industry? 目次1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Oligonucleotide Synthesis Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Synthesized Oligonucleotide Products 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Reagents 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Equipment 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Services 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Application 7.1 PCR Primers 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 PCR Assays and Panels 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Sequencing 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 DNA Microarrays 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Fluorescence In-Situ Hybridization (FISH) 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Antisense Oligonucleotides 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Others 7.7.1 Market Trends 7.7.2 Market Forecast 8 Market Breakup by End Use 8.1 Pharmaceutical and Biotechnology Companies 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Hospital and Diagnostic Laboratories 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Academic Research Institutes 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Agilent Technologies Inc. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 Financials 14.3.1.4 SWOT Analysis 14.3.2 Biolegio B.V. 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.3 Bio-Synthesis Inc 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Eurofins Genomics 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.5 GenScript 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.6 Horizon Discovery Ltd 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.7 Integrated DNA Technologies Inc (Danaher Corporation) 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.8 Kaneka Eurogentec S.A. (Kaneka Corporation) 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.9 LGC Limited 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.10 Nitto Denko Avecia Inc (Nitto Denko Corporation) 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.11 Thermo Fisher Scientific Inc. 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.11.3 Financials 14.3.11.4 SWOT Analysis
SummaryThe global oligonucleotide synthesis market exhibited strong growth during 2015-2020. Oligonucleotide synthesis is a chemical process wherein short fragments of nucleic acids are linked to each other for forming desired sequenced products. It can be customized by researchers according to the application and their requirements. It is used as primers and probes in recombinant DNA technologies to develop monoclonal antibodies. It is also utilized in biological, medical, forensic, and clinical applications for gene expression, cloning, molecular diagnostics, and genetic disease screening. Moreover, it is gaining traction in therapeutics practices for several drugs on account of the introduction of automated reactor platforms, which provide access to oligonucleotides at reasonable prices.With the increasing cases of coronavirus disease (COVID-19) and the urgency for a potential treatment, new generations of oligonucleotide drugs, including mRNA and DNA vaccines, are currently under development. Apart from this, the growing incidences of cancer and other chronic illnesses have resulted in the rising demand for novel diagnostics, which is influencing the need for oligonucleotide synthesis to help develop effective therapies and diagnostic techniques. The increasing geriatric population and demand for personalized medicines are also bolstering the market growth. Additionally, with advances in purification and quality control technologies, the overall cost of oligonucleotide techniques can be decreased while substantially increasing quality and yield. This is promoting the application of oligonucleotide synthesis in a range of available modifications. Apart from this, several oligonucleotide-based therapies are in different stages of clinical trials. This is anticipated to propel the demand for oligonucleotide synthesis to treat viral infections, rare genetic disorders, and neuromuscular conditions. Looking forward, IMARC Group expects the global oligonucleotide synthesis market to grow at a CAGR of 12.7% during the forecast period (2021-2026). Key Market Segmentation: IMARC Group provides an analysis of the key trends in each sub-segment of the global oligonucleotide synthesis market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, application and end use. Breakup by Product: Synthesized Oligonucleotide Products Reagents Equipment Services Breakup by Application: PCR Primers PCR Assays and Panels Sequencing DNA Microarrays Fluorescence In-Situ Hybridization (FISH) Antisense Oligonucleotides Others Breakup by End Use: Pharmaceutical and Biotechnology Companies Hospital and Diagnostic Laboratories Academic Research Institutes Breakup by Region: North America United States Canada Asia-Pacific China Japan India South Korea Australia Indonesia Others Europe Germany France United Kingdom Italy Spain Russia Others Latin America Brazil Mexico Others Middle East and Africa Competitive Landscape: The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Biolegio B.V., Bio-Synthesis Inc, Eurofins Genomics, GenScript, Horizon Discovery Ltd, Integrated DNA Technologies Inc (Danaher Corporation), Kaneka Eurogentec S.A. (Kaneka Corporation), LGC Limited, Nitto Denko Avecia Inc (Nitto Denko Corporation) and Thermo Fisher Scientific Inc. Key Questions Answered in This Report: How has the global oligonucleotide synthesis market performed so far and how will it perform in the coming years? What has been the impact of COVID-19 on the global oligonucleotide synthesis market? What are the key regional markets? What is the breakup of the market based on the product? What is the breakup of the market based on the application? What is the breakup of the market based on the end use? What are the various stages in the value chain of the industry? What are the key driving factors and challenges in the industry? What is the structure of the global oligonucleotide synthesis market and who are the key players? What is the degree of competition in the industry? Table of Contents1 Preface2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Oligonucleotide Synthesis Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Synthesized Oligonucleotide Products 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Reagents 6.2.1 Market Trends 6.2.2 Market Forecast 6.3 Equipment 6.3.1 Market Trends 6.3.2 Market Forecast 6.4 Services 6.4.1 Market Trends 6.4.2 Market Forecast 7 Market Breakup by Application 7.1 PCR Primers 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 PCR Assays and Panels 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Sequencing 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 DNA Microarrays 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Fluorescence In-Situ Hybridization (FISH) 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Antisense Oligonucleotides 7.6.1 Market Trends 7.6.2 Market Forecast 7.7 Others 7.7.1 Market Trends 7.7.2 Market Forecast 8 Market Breakup by End Use 8.1 Pharmaceutical and Biotechnology Companies 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 Hospital and Diagnostic Laboratories 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Academic Research Institutes 8.3.1 Market Trends 8.3.2 Market Forecast 9 Market Breakup by Region 9.1 North America 9.1.1 United States 9.1.1.1 Market Trends 9.1.1.2 Market Forecast 9.1.2 Canada 9.1.2.1 Market Trends 9.1.2.2 Market Forecast 9.2 Asia-Pacific 9.2.1 China 9.2.1.1 Market Trends 9.2.1.2 Market Forecast 9.2.2 Japan 9.2.2.1 Market Trends 9.2.2.2 Market Forecast 9.2.3 India 9.2.3.1 Market Trends 9.2.3.2 Market Forecast 9.2.4 South Korea 9.2.4.1 Market Trends 9.2.4.2 Market Forecast 9.2.5 Australia 9.2.5.1 Market Trends 9.2.5.2 Market Forecast 9.2.6 Indonesia 9.2.6.1 Market Trends 9.2.6.2 Market Forecast 9.2.7 Others 9.2.7.1 Market Trends 9.2.7.2 Market Forecast 9.3 Europe 9.3.1 Germany 9.3.1.1 Market Trends 9.3.1.2 Market Forecast 9.3.2 France 9.3.2.1 Market Trends 9.3.2.2 Market Forecast 9.3.3 United Kingdom 9.3.3.1 Market Trends 9.3.3.2 Market Forecast 9.3.4 Italy 9.3.4.1 Market Trends 9.3.4.2 Market Forecast 9.3.5 Spain 9.3.5.1 Market Trends 9.3.5.2 Market Forecast 9.3.6 Russia 9.3.6.1 Market Trends 9.3.6.2 Market Forecast 9.3.7 Others 9.3.7.1 Market Trends 9.3.7.2 Market Forecast 9.4 Latin America 9.4.1 Brazil 9.4.1.1 Market Trends 9.4.1.2 Market Forecast 9.4.2 Mexico 9.4.2.1 Market Trends 9.4.2.2 Market Forecast 9.4.3 Others 9.4.3.1 Market Trends 9.4.3.2 Market Forecast 9.5 Middle East and Africa 9.5.1 Market Trends 9.5.2 Market Breakup by Country 9.5.3 Market Forecast 10 SWOT Analysis 10.1 Overview 10.2 Strengths 10.3 Weaknesses 10.4 Opportunities 10.5 Threats 11 Value Chain Analysis 12 Porters Five Forces Analysis 12.1 Overview 12.2 Bargaining Power of Buyers 12.3 Bargaining Power of Suppliers 12.4 Degree of Competition 12.5 Threat of New Entrants 12.6 Threat of Substitutes 13 Price Analysis 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Agilent Technologies Inc. 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 Financials 14.3.1.4 SWOT Analysis 14.3.2 Biolegio B.V. 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.3 Bio-Synthesis Inc 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.4 Eurofins Genomics 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.5 GenScript 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.6 Horizon Discovery Ltd 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.7 Integrated DNA Technologies Inc (Danaher Corporation) 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.8 Kaneka Eurogentec S.A. (Kaneka Corporation) 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.9 LGC Limited 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.10 Nitto Denko Avecia Inc (Nitto Denko Corporation) 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.11 Thermo Fisher Scientific Inc. 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.11.3 Financials 14.3.11.4 SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（遺伝子解析）の最新刊レポート
IMARC Services Private Limited. 社の最新刊レポート本レポートと同じKEY WORD（oligonucleotide）の最新刊レポート
よくあるご質問IMARC Services Private Limited.社はどのような調査会社ですか?インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/07/05 10:26 162.17 円 175.82 円 209.73 円 |
